The Prognostic Implication of Inflammatory Factor-Based Scoring System in Diffuse Large B-Cell Lymphoma Patients in the Rituximab Era

被引：0
|
作者：
Lee, Ji Hyun
Oh, Sung Yong
Jo, Jae-Cheol
Choi, Yunsuk
Shin, Ho-Jin
Lee, Won-Sik
Kyung, Kwon A.
Lee, Yoojin
Lee, Ho Sup
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4142
引用
收藏
页数：3
相关论文
共 50 条
  • [21] An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era
    Sun, Feifei
    Zhu, Jia
    Lu, Suying
    Zhen, Zijun
    Wang, Juan
    Huang, Junting
    Ding, Zonghui
    Zeng, Musheng
    Sun, Xiaofei
    BMC CANCER, 2018, 18
  • [22] An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era
    Feifei Sun
    Jia Zhu
    Suying Lu
    Zijun Zhen
    Juan Wang
    Junting Huang
    Zonghui Ding
    Musheng Zeng
    Xiaofei Sun
    BMC Cancer, 18
  • [23] Diminishing prognostic role of preexisting diabetes mellitus for patients with diffuse large B-cell lymphoma in the rituximab era
    Hsueh-Ju Lu
    Yu-Chung Huang
    Chun-Yu Liu
    Man-Hsin Hung
    Ming-Hung Hu
    Chia-Yun Wu
    Ying-Chung Hong
    Liang-Tsai Hsiao
    Jyh-Pyng Gau
    Jin-Hwang Liu
    Hui-Chi Hsu
    Tzeon-Jye Chiou
    Cheng-Hwai Tzeng
    Yuan-Bin Yu
    Annals of Hematology, 2013, 92 : 1495 - 1501
  • [24] Prognostic impact for different sites of extranodal involvement in patients with diffuse large B-cell lymphoma in the rituximab era
    Takahashi, H.
    Tomita, N.
    Yokoyama, M.
    Tsunoda, S.
    Yano, T.
    Murayama, K.
    Hashimoto, C.
    Tamura, K.
    Sato, K.
    Fujita, H.
    Ishigatsubo, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] PROGNOSTIC IMPACT FOR DIFFERENT SITES OF EXTRANODAL INVOLVEMENT IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN THE RITUXIMAB ERA
    Takahashi, H.
    Tomita, N.
    Yokoyama, M.
    Tsunoda, S.
    Yano, T.
    Murayama, K.
    Hashimoto, C.
    Tamura, K.
    Sato, K.
    Ishigatsubo, Y.
    ANNALS OF ONCOLOGY, 2011, 22 : 195 - 195
  • [26] Diminishing prognostic role of preexisting diabetes mellitus for patients with diffuse large B-cell lymphoma in the rituximab era
    Lu, Hsueh-Ju
    Huang, Yu-Chung
    Liu, Chun-Yu
    Hung, Man-Hsin
    Hu, Ming-Hung
    Wu, Chia-Yun
    Hong, Ying-Chung
    Hsiao, Liang-Tsai
    Gau, Jyh-Pyng
    Liu, Jin-Hwang
    Hsu, Hui-Chi
    Chiou, Tzeon-Jye
    Tzeng, Cheng-Hwai
    Yu, Yuan-Bin
    ANNALS OF HEMATOLOGY, 2013, 92 (11) : 1495 - 1501
  • [27] Prognostic Implication Of Circulating Vascular Endothelial Growth Factor In Patients With Diffuse Large B-Cell Lymphoma
    Lee, Hyewon
    Eom, Hyeon-Seok
    Kim, Min Kyeong
    Kim, Hyun-Ju
    Park, Weon Seo
    Kong, Sun-Young
    BLOOD, 2013, 122 (21)
  • [28] Outcomes of Cardiac Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Al-Juhaishi, Taha
    Abu Zeinah, Ghaith
    Al-Kindi, Sadeer
    BLOOD, 2020, 136
  • [29] Primary breast diffuse large B-cell lymphoma in the era of rituximab
    Zhang, Na
    Cao, Caineng
    Zhu, Yuan
    Liu, Peng
    Liu, Luying
    Lu, Ke
    Luo, Jialin
    Zhou, Ning
    ONCOTARGETS AND THERAPY, 2016, 9 : 6093 - 6097
  • [30] Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Cheng, Chieh-Lung
    Huang, Sheng-Chuan
    Chen, Jia-Hong
    Wei, Chao-Hung
    Fang, Wei-Quan
    Su, Tung-Hung
    Yuan, Chang-Tsu
    Liu, Jia-Hau
    Chuang, Ming-Kai
    Tien, Hwei-Fang
    ONCOLOGIST, 2020, 25 (09): : 793 - 802
12345